ATE327758T1 - In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil - Google Patents

In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil

Info

Publication number
ATE327758T1
ATE327758T1 AT03709892T AT03709892T ATE327758T1 AT E327758 T1 ATE327758 T1 AT E327758T1 AT 03709892 T AT03709892 T AT 03709892T AT 03709892 T AT03709892 T AT 03709892T AT E327758 T1 ATE327758 T1 AT E327758T1
Authority
AT
Austria
Prior art keywords
piribedil
pharmaceutical composition
composition containing
dispersible pharmaceutical
oral dispersible
Prior art date
Application number
AT03709892T
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE327758T1 publication Critical patent/ATE327758T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT03709892T 2002-01-21 2003-01-21 In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil ATE327758T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200671A FR2834894B1 (fr) 2002-01-21 2002-01-21 Composition pharmaceutique orodispersible de piribedil

Publications (1)

Publication Number Publication Date
ATE327758T1 true ATE327758T1 (de) 2006-06-15

Family

ID=27589523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709892T ATE327758T1 (de) 2002-01-21 2003-01-21 In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil

Country Status (27)

Country Link
US (1) US20050085485A1 (de)
EP (1) EP1467737B1 (de)
JP (1) JP4500051B2 (de)
KR (1) KR100588223B1 (de)
CN (1) CN100352440C (de)
AR (1) AR038194A1 (de)
AT (1) ATE327758T1 (de)
AU (1) AU2003214326B2 (de)
BR (1) BR0306869A (de)
CA (1) CA2473152C (de)
CY (1) CY1105414T1 (de)
DE (1) DE60305642T2 (de)
DK (1) DK1467737T3 (de)
EA (1) EA007286B1 (de)
ES (1) ES2263959T3 (de)
FR (1) FR2834894B1 (de)
GE (1) GEP20063819B (de)
HK (1) HK1081110A1 (de)
MA (1) MA27098A1 (de)
MX (1) MXPA04007035A (de)
NO (1) NO20043474L (de)
NZ (1) NZ533820A (de)
PL (1) PL204939B1 (de)
PT (1) PT1467737E (de)
UA (1) UA78277C2 (de)
WO (1) WO2003061661A1 (de)
ZA (1) ZA200405008B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (de) * 1955-09-09
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
JP3122141B2 (ja) * 1994-01-31 2001-01-09 山之内製薬株式会社 口腔内溶解型圧縮成型物及びその製造法
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
EP1007083A1 (de) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisierung von wässrigen interferon-lösungen zur herstellung von sublingualen tabletten
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
AU2001273496A1 (en) * 2000-07-24 2002-02-05 Boehringer Ingelheim Pharmaceuticals Inc. Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
EP1175899B1 (de) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granulat bestehend aus Stärke und Laktose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
ZA200405008B (en) 2005-08-31
CN1688313A (zh) 2005-10-26
DK1467737T3 (da) 2006-09-18
EP1467737A1 (de) 2004-10-20
AU2003214326B2 (en) 2007-08-02
JP2005529068A (ja) 2005-09-29
NZ533820A (en) 2005-08-26
UA78277C2 (en) 2007-03-15
CN100352440C (zh) 2007-12-05
EA007286B1 (ru) 2006-08-25
PT1467737E (pt) 2006-08-31
FR2834894A1 (fr) 2003-07-25
PL370168A1 (en) 2005-05-16
EA200400885A1 (ru) 2004-12-30
AR038194A1 (es) 2005-01-05
DE60305642T2 (de) 2007-05-16
EP1467737B1 (de) 2006-05-31
KR100588223B1 (ko) 2006-06-12
HK1081110A1 (en) 2006-05-12
ES2263959T3 (es) 2006-12-16
GEP20063819B (en) 2006-05-10
FR2834894B1 (fr) 2004-02-27
CA2473152A1 (fr) 2003-07-31
WO2003061661A1 (fr) 2003-07-31
JP4500051B2 (ja) 2010-07-14
BR0306869A (pt) 2004-11-03
PL204939B1 (pl) 2010-02-26
US20050085485A1 (en) 2005-04-21
KR20040075098A (ko) 2004-08-26
DE60305642D1 (de) 2006-07-06
MXPA04007035A (es) 2004-10-11
NO20043474L (no) 2004-08-20
CY1105414T1 (el) 2010-04-28
CA2473152C (fr) 2010-08-31
MA27098A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
ATE324882T1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
DE60111769D1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
ATE355271T1 (de) Pharmazeutische zusammensetzung
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
ATE317260T1 (de) Pharmazeutische formulierungen mit platinderivaten
CY2007031I1 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE60213592D1 (de) Flüssige pharmazeutische zusammensetzung
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE366128T1 (de) Pharmazeutische zusammensetzung
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60330764D1 (de) Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
ATE332690T1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
ATE507831T1 (de) Melatonin enthaltende pharmazeutische formulierung
ATE327758T1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1467737

Country of ref document: EP